Cite Filings / APUS / 9999999995-25-001413

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Apimeds Pharmaceuticals US, Inc. Filed 2025-05-05 Acc 9999999995-25-001413

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2025-05-05 EFFECT Notice of Effectiveness
2025-05-05 CORRESP Correspondence Between Filers and SEC Staff
2025-05-05 CORRESP Correspondence Between Filers and SEC Staff
2025-05-05 UPLOAD SEC-generated Letter
2025-05-02 POS AM Post-effective Amendment for Registration Statement
2025-05-02 10-K/A 10-K/A
2025-02-11 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…